CHE (Roto-Rooter) Net earnings per share for the last 12 months

CHE (Roto-Rooter) - company brandmark

Despite wage inflation pressure and healthcare staffing shortages, the trailing 12-month EPS demonstrates resilience, with 20.93 representing the current level of the metric. This chart confirms the effectiveness of the hospice acquisition strategy funded by revenues from the plumbing service. The success of Chemed Corporation (CHE) is based on inelastic demand in both niches, which guarantees high margins.

CHE (Chemed Corporation) Net earnings per share for the last 12 months history from 07/04/2022 to 11/16/2026

Analytical breakdowns for Chemed Corp (CHE)

- stock price and consensus target price:
Summary company analysis:CHE - Chemed Corp
Mass-produced product of VITAS Healthcare

This metric reflects the actual equity value of the business, dividing total annual net income by the total number of shares to evaluate profit generation efficiency. Steady growth in the TTM net income per share confirms the success of the Chemed Corporation (CHE) strategy of reinvesting Roto-Rooter cash flows into the expansion of the VITAS hospice network amid the aging US population.